Investing Profile

Johannes Zanzinger

InvestorVC
Investment Manager at Boehringer Ingelheim Venture Fund
Photo of Johannes Zanzinger, Investor at Boehringer Ingelheim Venture Fund
cb
$3.3M - $17.0M
$8.5M
3
CompanyStageDateRound SizeTotal Raised
DiogenX
Series AMay 2023$37M
SeedJun 2020$5M
$42M
Co-investors: Katie Ellias (T1D Fund)
Centauri Therapeutics
Series AFeb 2022$33M
$33M
Co-investors: Sebastian Kreuz (Boehringer Ingelheim Venture Fund)